- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/50 - Proteinases
Patent holdings for IPC class C12N 9/50
Total number of patents in this class: 983
10-year publication summary
80
|
66
|
55
|
69
|
107
|
68
|
75
|
76
|
79
|
32
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3314 |
58 |
The Regents of the University of California | 18943 |
23 |
Allergan, Inc. | 2600 |
16 |
Ipsen Bioinnovation Limited | 57 |
14 |
Massachusetts Institute of Technology | 9795 |
13 |
University of Washington | 2157 |
13 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
12 |
Codexis, Inc. | 776 |
11 |
Sandoz AG | 1392 |
10 |
President and Fellows of Harvard College | 5792 |
10 |
Danisco US Inc. | 1045 |
10 |
Lysando AG | 50 |
10 |
DSM IP Assets B.V. | 5856 |
9 |
California Institute of Technology | 3884 |
8 |
Jiangnan University | 1410 |
7 |
Alcresta Therapeutics, Inc. | 37 |
6 |
Amano Enzyme Inc. | 324 |
6 |
Boehringer Ingelheim RCV GmbH & Co KG | 56 |
6 |
Carbios | 117 |
6 |
The University of North Carolina at Chapel Hill | 1928 |
6 |
Other owners | 729 |